Medikaloka Hermina Tbk PT
IDX:HEAL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 070
1 595
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Medikaloka Hermina Tbk PT
PP&E Gross
Medikaloka Hermina Tbk PT
PP&E Gross Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
PP&E Gross
Rp7.8T
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
||
Siloam International Hospitals Tbk PT
IDX:SILO
|
PP&E Gross
Rp7.5T
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
||
Metro Healthcare Indonesia Tbk PT
IDX:CARE
|
PP&E Gross
Rp3.3T
|
CAGR 3-Years
15%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
||
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
PP&E Gross
Rp4.3T
|
CAGR 3-Years
12%
|
CAGR 5-Years
19%
|
CAGR 10-Years
13%
|
|
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
|
PP&E Gross
Rp4.3T
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
17%
|
||
F
|
Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
|
PP&E Gross
Rp2.5T
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Medikaloka Hermina Tbk PT
Glance View
PT Medikaloka Hermina engages in healthcare services. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 15,086 full-time employees. The company went IPO on 2018-05-16. The firm is focused on providing services for BPJS patients to support government program in Indonesia. The Company’s services include hospitals, specialties and featured services. The Company’s hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology and surgery. The Company’s subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).
See Also
What is Medikaloka Hermina Tbk PT's PP&E Gross?
PP&E Gross
7.8T
IDR
Based on the financial report for Sep 30, 2024, Medikaloka Hermina Tbk PT's PP&E Gross amounts to 7.8T IDR.
What is Medikaloka Hermina Tbk PT's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
20%
Over the last year, the PP&E Gross growth was 28%. The average annual PP&E Gross growth rates for Medikaloka Hermina Tbk PT have been 19% over the past three years , 20% over the past five years .